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Abstract
While much attention has been focused on the molecular epidemiology of retroviruses in wild primate populations, the
correlated question of the frequency and nature of super-infection events, i.e., the simultaneous infection of the same
individual host with several strains of the same virus, has remained largely neglected. In particular, methods possibly
allowing the investigation of super-infection from samples collected non-invasively (such as faeces) have never been
properly compared. Here, we fill in this gap by assessing the costs and benefits of end-point dilution PCR (EPD-PCR) and
multiple bulk-PCR cloning, as applied to a case study focusing on simian foamy virus super-infection in wild chimpanzees
(Pan troglodytes). We show that, although considered to be the gold standard, EPD-PCR can lead to massive consumption of
biological material when only low copy numbers of the target are expected. This constitutes a serious drawback in a field in
which rarity of biological material is a fundamental constraint. In addition, we demonstrate that EPD-PCR results (single/
multiple infection; founder strains) can be well predicted from multiple bulk-PCR clone experiments, by applying simple
statistical and network analyses to sequence alignments. We therefore recommend the implementation of the latter
method when the focus is put on retroviral super-infection and only low retroviral loads are encountered.
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Introduction
The genetic diversity of African primate retroviruses has
attracted considerable research efforts, some of which notably
led to the identification of the original reservoir of the human
immunodeficiency viruses in west and central African primates
[1]. Many of these works have also allowed the rough determi-
nation of prevalence rates for a number of retrovirus/host systems
[2]. Simian immunodeficiency viruses (SIV), simian T-cell
leukaemia viruses type 1 (STLV-1) and simian foamy viruses
(SFV) could all be shown to reach high prevalence rates (.50%) in
at least some of their host species [2–6]. In these conditions, it
seems reasonable to predict that retroviral super-infection, here
defined as the simultaneous infection of the same individual host
with several strains of the same virus, will occur frequently in (at
least) some wild primate hosts.
Retroviral super-infection could significantly contribute to
shaping in-host retroviral diversity, which otherwise mainly
depends on in-host accumulation of mutations, i.e., the develop-
ment of quasispecies. Even rare super-infection events might have
a tremendous biological significance. Those may indeed bring
together retroviral strains far more divergent than those found
within quasispecies and result in major recombination-based
genome shuffling, the very process that for example gave rise to
the simian precursor of HIV-1 [7]. Despite its theoretical
importance, the occurrence of retroviral super-infection in wild
primate hosts essentially remains an untested hypothesis.
While investigating co-infection with retroviruses belonging to
distinct genera does not raise any specific technical difficulty since
independent, genus-specific serological/molecular methods will
often be used (e.g., [2,8]), studying super-infection appears more
challenging. Indeed, even though direct sequencing or heterodu-
plex mobility assays of bulk-PCR products might allow detecting
heterogeneous retroviral populations of a same species, e.g., HIV-1
subtypes or variants [9,10], a truly complete depiction of bulk-
PCR product contents will require using some kind of dissection
method. For the latter purpose, cloning and sequencing or next
generation sequencing (NGS) can be implemented. Both methods
are, however, known to be prone to Taq-induced errors while
cloning can result in selective biases since some sequences will be
more likely to be cloned than others [11]. This recently prompted
the rise of end point dilution PCR (EPD–PCR) - which is
independent of preliminary bulk-PCR amplification - as the gold
standard for the depiction of intra-individual retroviral diversity
[11,12]. Within this framework, EPD-PCR was successfully
applied to the investigation of HIV-1 micro-evolutionary trends
(e.g., [13]), including the detection of super-infection events (e.g.,
[14]).
EPD-PCR might therefore be considered a promising tool for
the detection of super-infection cases among wild primate hosts.
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implementation in this context. As retrovirus-oriented studies of
wild primate populations essentially rely on the analysis of non-
invasively collected samples (most often faeces, e.g., [4,15]), it is
conceivable that samples will only contain retroviral/proviral
genomes in minute amounts [16]. Acquiring a substantial sample
of EPD-PCR sequences might therefore require prohibitively large
amounts of, by definition, rare starting material [17]. Thus,
applying initially biased methods might sometimes be preferable as
long as the tools exist to extract biological signal from biased
datasets.
In the present study, we investigate super-infection with simian
foamy viruses (SFV) in wild western and eastern chimpanzees (Pan
troglodytes verus and P. t. schweinfurthii). We first show that, while SFV
infection occurs in these ape populations, SFV retroviral/proviral
loads, as quantified from faeces, are extremely low. Making use of
this example, we then investigate in greater detail the costs and
benefits associated to EDP-PCR and concurrent bulk-PCR based
methods when only low quality samples are available whereby the
explicit focus is placed on the detection of super-infection.
Materials and Methods
Sample Description
Faecal samples were collected from two habituated communities
of chimpanzees living in western and eastern Africa - P. t. verus
from Taı ¨ National Park, Co ˆte d’Ivoire and P. t. schweinfurthii from
Budongo Forest Reserve, Uganda. All necessary permissions were
obtained for the described field studies - from the Ministry of the
Environment and Forests, the Ministry of Research and the
directorship of the Taı ¨ National Park for the study site in Co ˆte
d’Ivoire and from the Uganda Wildlife Authority and the Uganda
National Council for Science and Technology for the study site in
Uganda. Faecal samples were placed on ice (Taı ¨ samples) or
soaked in RNAlater (Qiagen, Hilden, Germany; Budongo
samples) directly after collection, before being stored in liquid
nitrogen (Taı ¨ samples) or at 220uC (Budongo samples), as
previously described [17,18]. Because primary infection with
SFV is assumed to occur in early adulthood [4,19], samples were
selected from individuals older than ten years of age at the date of
collection (range: 15–42 years). All details about individual samples
are given in Table S1.
Molecular Biology Analyses
Nucleic acids’ extraction and cDNA generation. DNA
and RNA were co-extracted with the GeneMATRIX Stool DNA
Purification Kit (Roboklon GmbH, Berlin, Germany) using 80 mg
faeces (Taı ¨ samples) or 100 mL homogenate (Budongo samples)
and 5 ml carrier RNA (Qiagen, Hilden, Germany) to enhance
RNA yield. First-strand cDNA synthesis was then performed using
SuperScript
TM II RT (Invitrogen
TM, Karlsruhe, Germany) with
random hexamer primers. We did not consider RNA genomes as
our specific targets. Therefore, extracts were not treated with
DNAse so as to allow for the detection of SFV DNA (either
packaged in viral particles or proviral), would it occur in faecal
samples. Though published results suggest that SFV DNA will be
shed much less frequently in faeces than SFV RNA [4], it should
be considered that any sequence produced here might come from
RNA or DNA genomes found in viral particles or shed infected
cells or from proviral DNA.
Initial PCR screening. To identify positive faeces, a nested
PCR assay using a set of generic primers targeting a 470 base pair
(bp) fragment of the integrase (int) gene was employed [first round
primers: PFVint1s, 59-GCCACCCAAGGGAGTTATGTGG-39,
PFVint2as, 59-GCTGCACCCTGATCAGAGTG-39; second
round primers: PFVint3s, 59-CCTGGATGCAGAGTTG-
GATC-39, PFVint4as, 59-GAAGGAGCCTTAGTGGGGTA-39;
4,20], using 1.5 ml cDNA as template in a 15 ml reaction mixture
containing PlatinumH Taq DNA-Polymerase (Invitrogen
TM,
Karlsruhe, Germany). Among many positive samples, six
(obtained from two males and four females from TNP) were then
tested with a TaqMan probe-based quantitative assay targeting
another short fragment of the polymerase gene (pol; primers sense,
59-CTTCAACCTTTGCTGAATG-39, and antisense, 59-TAA-
TACAGGGCTATAGGTGT-39; TaqMan probe 69-FAM-
TTGGAATTCAGTACTCCTTATCACCC-39-BHQ1), using
2 ml cDNA as template in reactions otherwise prepared as in
[21]. This assay was also tested on dilutions of plasmids containing
the corresponding sequence and could detect ,5 molecules per
reaction, including when plasmids were mixed in ‘‘faecal’’ SFV-
negative cDNA (data not shown). The final sample set examined in
this study included these six samples as well as four positive faeces
samples from Budongo (obtained from two males and two
females). The latter were not tested with qPCR as they were only
available as RNAlater homogenate, which prevented determining
the mass of faecal matter effectively used (faecal matter mass was
not determined at the time of collection).
End-point dilution PCR. Several dilutions of cDNA were
tested for each isolate so as to identify the dilutions resulting in
success rates ,30%, conditions in which about 80% of the
sequences can be predicted to stem from a single starting template
molecule [11]. For each individual, 15 EPD-PCR products were
sequenced on both strands according to the Sanger’s method. A
fasta file comprising all unique EPD-PCR sequences is available at
http://www.sebastiencalvignac.fr.
Bulk-PCR and cloning. Five positive bulk-PCR products
were also obtained from each individual, using the same
aforementioned nested PCR assay, which was run using 1.5 mL
undiluted cDNA as template (cDNA was always derived from the
same faecal sample as used for EPD-PCR). All resulting PCR
products were sub-cloned using a Topo TA cloning kit (Invitro-
gen
TM, Karlsruhe, Germany) according to the manufacturer’s
instructions. Following colony PCR and visualisation on a 1.5%
agarose gel, five positive colony PCR products from each of the
amplicons were purified and sequenced on both strands according
to the Sanger’s method, thereby generating 25 clone sequences per
individual. It should be noted here that we purportedly chose to
target a conserved region of the SFV genome and to use a normal
(as opposed to high-fidelity) Taq polymerase to produce the
amplicons to be analysed. Our rationale for that was that, by
maximizing Taq-induced noise in a context of limited diversity, we
would provide the harshest possible substrate for the intended
statistical and network analyses.
Sequence Analysis
Sequence processing and preliminary
analyses. Chromatograms were analysed using SeqManHII
(DNASTARH Lasergene
TM DNAStar Inc., USA). Sequences
comprising mixed bases were discarded. The 400 unique
sequences that constituted the final dataset were aligned by eye
using SeaView v4 [22], before being checked for evidence of
recombination using the RDP, GENECONV, MaxChi, Chimae-
ra, SiScan, and 3Seq tools, as available in RDP3 v3.42 [23]. No
recombination event could be detected using these methods (but it
should be kept in mind that the short length and limited genetic
diversity of the sequences generated here limits the power of many
of these tests).
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calculated with SeaView. The phylogenetic signal content of each
alignment was then inspected using likelihood mapping, as
implemented in TREE-PUZZLE [24]. Phylogenetic analyses were
also performed in a maximum-likelihood framework, using
PhyML v3.0 [25] as implemented in SeaView and approximate
likelihood ratio test values as branch support values [26]. For all
datasets and analyses, a same model of nucleotide substitution was
employed (global time reversible plus rate heterogeneity;
GTR+G).
To specify the origin of the SFV sequences phylogenetic
analyses were also conducted on large datasets including all
sequences obtained from a given sup-species (P. t. verus or P. t.
schweinfurthii) to which representative sequences from SFV infecting
other great apes were also added. These control analyses were run
under maximum likelihood and Bayesian frameworks, using the
model of nucleotide substitution pointed at by the best Akaike’s
information criterion score (i.e., GTR+G), as determined by
jModelTest v.0.0.1 [27]. PhyML was run on a webserver [28],
using bootstrap pseudo-replicates (n=500) as a way to investigate
branch robustness. Bayesian analyses were performed using
BEAST v1.6.1 [29]. Output of BEAST analyses were examined
with companion softwares (available at http://beast.bio.ed.ac.uk/
Main_Page), which notably allowed for the computation of branch
posterior probabilities, which were taken as branch robustness
measures. Both maximum likelihood and Bayesian analyses
supported the expected scheme of sub-species specific distribution
of SFV [4] (data not shown).
Statistical Analyses
Our first objective was to develop a statistical tool that provides
an objective criterion for classifying individuals as single or super-
infected, based on the analysis of a multiple bulk-PCR product
clone alignment. We chose to use the shape of the frequency
distribution of the number of mismatches derived from an
individual clone alignment (thereafter termed ‘mismatch distribu-
tion’) as a way to investigate the nature of the underlying infection
process. Briefly, our assumption was that in case of single infection,
mismatch distribution should be approximately unimodal and can
be fit with ‘‘unimodal’’ distribution laws. On the contrary, we
expected that super-infection would result in bi- or multimodal
distributions and should therefore better fit ‘‘bimodal’’ distribution
laws.
We first produced mismatch distributions for all individual
EPD-PCR sequence alignments and identified the individuals as
cases of single or super-infection. At that stage, assignment was
made by eye only as the limited number of variants precluded any
statistical assessment of the shape of the distributions.
We then investigated the shape of the much more variable
mismatch distributions derived from bulk-PCR product clone
alignments. To objectively measure whether (or to what extent)
such a distribution was bimodal, we once assumed that the
distribution was from a single (normal or Poisson) distribution and
once assumed that it was from two normal distributions with equal
standard deviations but different means or from two Poisson
distributions. For all four assumptions we determined the most
likely mean or means and the most likely standard deviation (in
case of the normal distribution(s) assumption) using maximum
likelihood. We then calculated Akaike’s information criterion,
corrected for small samples (AICc) as a measure of model
performance [30] and selected the model with the smallest AICc
as the most likely mismatch distribution (uni- or bi-modal normal
or Poisson distribution). However, when the smallest AICc-value
differed by no more than two from the second smallest, we chose
the simplest model (i.e., the one with the smallest number of
estimated parameters) from all models with AICc-values differing
from the smallest AICc-value by at most two (in case the model
with one normal distribution and the model with two Poisson
distributions both fulfilled this criterion, we chose the one with the
smaller AICc). For each individual, we applied this approach to
any possible combination of bulk-PCR product clone alignments;
i.e., to the only possible combination of all five bulk-PCR product
clone alignments (ABCDE), to the five possible combinations of
four bulk-PCR product clone alignments (ABCD, ABCE, ABDE,
ACDE and BCDE), and so on. In a few cases only two different
numbers of mismatches were found in a sample. In these cases we
assessed uni2/bimodality based on visual inspection of the
distribution because it was impossible to fit the two means model
to such a distribution.
We also applied this approach to simulated cases of triple
infection. The latter consisted of robust clone ‘‘clouds’’ (supported
by both phylogenetic and network analyses, from Taı ¨ specimens
only) which were shuffled randomly so as to form 84 ‘‘triple
infection clone alignments’’.
All analyses were conducted in R (version 2.10.1, R Develop-
ment Core Team 2010) using scripts written by one of us (RM).
Network Analyses
Sequences generated with EPD-PCR are in principle Taq-error
free sequences [11]. This is not the case of clone sequences, which
will on the contrary often harbour singleton changes due to Taq
errors. We were therefore also interested in defining a method that
would allow for the identification of biological sequences
potentially comprised in clone alignments (including minor
variants) and more particularly of those sequences which might
be at the origin of the infection and/or have become main
components of the overall retroviral population (hereafter called
founder sequences).
Founder sequences with respect to their biological variants-–
but also biological sequences with respect to their Taq-modified
variants – are expected to exhibit two distinctive properties: i) high
connectivity and ii) high frequency. While phylogenetic analyses
cannot capture these characteristics, tokogenetic analyses (i.e.
network building) can in principle allow for their simultaneous
assessment [31]. TCS [32], which implements statistical parsimo-
ny-based network building as initially described in an article by
Templeton, Crandall and Sing (1992; [33]), offers the advantage
to produce ‘‘outgroup probabilities’’ (OP), a statistic which
summarizes sequence connectivity and frequency for all sequences
examined.
We first identified EPD-PCR sequences having the highest OPs
(either the very best if single infection or the two best ones if super-
infection) and checked whether highest OPs derived from clone
alignments pointed at the same founder sequences. We also
checked whether the appearance of a sequence in several of the
five PCR products (ability to replicate) was likely to point at it
being a founder sequence. We determined OP values from all
possible alignments derived from 3 or 4 PCR products only and in
which no sequence was appearing in more than one PCR product
so as to determine whether OPs were pointing at EPD-PCR
founder sequences when ability to replicate could not be used as a
criterion.
Finally, we also built TCS networks for 9 of the 84 simulated
triple infection cases and checked whether the three highest OPs
were pointing to the appropriate ‘‘clouds’’ of sequences.
For all alignments, median-joining networks [34] were also
reconstructed using Network v4.610 (www.fluxus-engineering.
com). Those were always similar in shape to their statistical
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in this article, as their layout could be much more easily reworked,
using a dedicated tool, Network Publisher (www.fluxus-
engineering.com).
Results
Quantification of SFV Retroviral Loads in Faeces
Quantitative PCR performed on samples identified as positive
by a nested PCR approach resulted in negative results for the six
Figure 1. Mismatch distribution analyses of EPD-PCR and clone sequence datasets. Individuals are ordered such that first four individuals
with a single infection (as determined by EPD-PCR) are shown (B2, B3, B4 and T3; above the bar) followed by individuals with super-infections (below
the bar). Plots are paired for each individual with the EPD-PCR dataset on the left and the bulk-PCR clone dataset on the right. EPD-PCR distributions
are black; bulk-PCR clone distributions identified as unimodal (DAICc,2) are green; bulk-PCR clone distributions identified as bimodal are purple
(DAICc.2).
doi:10.1371/journal.pone.0036570.g001
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sensitivity (detection threshold ,5 molecules). When extrapolating
to the 80 mg faeces typically used for extraction, this suggested
that SFV retroviral/proviral loads in faeces are in the range of at
maximum a handful of copies per mg faeces.
EPD-PCR
For each selected sample, we aimed at acquiring a minimum of
15 EPD-PCR sequences, a point at which the average nucleotide
distance most often reached a plateau, thereby suggesting
appropriate sampling of the underlying viral population (Figure
S1). Moderate dilutions (down to a maximum factor of 20) were
always sufficient to lower the success rate to less than 30% of the
reactions (Table S1) [11]. On average, 69.3 mL of undiluted
cDNA was necessary to gather the desired number of EPD-PCR
sequences, though the range of used material was highly variable
(median volume: 47 mL, range: 11–179 mL; Table S2).
In all cases, several unique SFV sequences were identified by
EPD-PCR (range: 2–5). These sequences were all assumed to
represent authentic biological variants and therefore directly used
to make a decision regarding chimpanzee-specific SFV super-
infection, using mismatch distributions. This way, eight of the 10
individuals could be unambiguously assigned as single or super-
infected (6/6 P. t. verus: T1 to T6, 2/4 P. t. schweinfurthii: B1 and
B4; Figure 1). The two remaining individuals (B2 and B3)
exhibited slightly ambiguous distributions but were ultimately
assigned to the single infection category, based on a rather small
maximum divergence of 5 bp (as compared to a minimum of 7 bp
difference between different strains and a mean of 10 bp for
unambiguously super-infected individuals).
Bulk-PCR Product Cloning and Sequencing
For each sample we generated five bulk-PCR products,
consuming a median volume of 12.5 mL undiluted cDNA. All
resulting PCR products (named A to E) were sub-cloned and five
clones were sequenced per product. Clone alignments typically
exhibited higher levels of polymorphism than the corresponding
EPD-PCR sequence alignments, an expected consequence of the
accumulation of random Taq-errors (e.g., Figure S2).
Simple statistics computed from individual alignments, such as
the mean observed distance among clones or the percentage of
resolved/unresolved topologies obtained using quartet puzzling
analysis (i.e., likelihood mapping), did not correlate well with
infection status as determined through EPD-PCR sequence
analysis, even though trends could be observed (Table S3). In
addition, the proportion of unresolved quartets in the likelihood
mapping analyses (32.5–98.2%; Table S3) suggested alignments
only comprised little phylogenetic information.
Assessing the shape of the mismatch distribution (uni- or bi-
modal) for the 10 complete clone alignments (i.e., all 25 sequences
stemming from five bulk-PCR products of a subject), allowed to
properly infer individual status with respect to super-infection, as
revealed by EPD-PCR results, in 9 out of ten cases (Figure 1).
Using the same test it was also possible to investigate the impact of
the number of bulk-PCR products analysed on the super-infection
diagnostic. The latter revealed that the probability to infer single
infection for super-infected individuals (i.e., probability of a false
negative) was zero as soon as three or more products were
analysed (Figure 2a). The probability to infer super-infection for
single infected individuals (i.e., probability of a false positive) was
markedly higher (up to 80%; Figure 2b).
Identification of Founder Sequences
Sequences having likely founded the sampled retroviral
populations (or at least standing for major variants at the time of
sampling) were identified from EPD-PCR sequence alignments
using outgroup probabilities (OPs) generated by TCS. These EPD-
PCR founder sequences were actually captured in 14 of 16 cases
(here one case equals one founder sequence), when considering the
total five PCR products generated for each sample.
From these 14 clone sequences, 10 had been replicated.
Replication was generally not observed for other clone sequences,
with two exceptions. In the first case, two distinct clone sequences
determined from B4 were replicated (B4 had been identified as
single infected). Both sequences had been sampled through EPD-
PCR and were very closely related (1 bp divergence). In the
second case, a T1 clone sequence could be replicated which had
not been identified through EPD-PCR, thereby revealing a
possible example of erroneous replication-based identification of
EPD-PCR sequences or the sampling of a biological variant not
sampled by EPD-PCR.
TCS networks were also computed from all clone alignments
in order to assess the performance of OPs in pointing at EPD-
PCR-determined founder sequences. The overall shape of the
clone networks reflected expectations; ‘‘star-like’’ patterns were
commonly observed, thereby highlighting founder effects (both
biological and Taq-error dependent; Figure 3). Super-infected
individuals also exhibited more complex networks, which were
sometimes even disconnected (when computed using statistical
parsimony, data not shown; Figure 3). Phylogenetic analyses of
individual datasets always provided high support to the branch
defining distinct clouds of sequences in networks of super-infected
individuals (Table S3). In all the 14 aforementioned cases where
EPD-PCR-determined founder sequences had been sampled, the
highest or two highest OP values, for single and super-infected
individuals, respectively, highlighted the correct clone sequences
as founders (Table 1). The co-occurrence of two very closely
related sequences in B4 was also supported by OPs (Table 1). In
the two remaining cases - where one of the two EPD-PCR
founder sequences had not been captured by cloning – selecting
the sequences with the two highest OPs as potential founder
sequences involved would have resulted in: i) misleadingly
identifying a sequence closely related to the sampled EPD-PCR
founder sequence as the source of the second infection (clone b
from T2; Figure 3 and Table 1); and ii) being unable to identify
a second founder sequence (T6; Figure 3 and Table 1), as all
sequences differing from the first founder sequence were only
exhibiting the ‘‘noise’’ OP, i.e., the minimal OP value attributed
to poorly represented/connected sequences.
In order to allow further comparison of replication-based and
network/OP-based identification methods, we computed net-
works for all the possible combinations of three or four PCR
products for which EPD-PCR founder sequence(s) would not
have been replicated (n=41) (Table S4). Using OPs, EPD-PCR
Figure 2. False negativity and positivity as a function of the number of bulk-PCR products analysed. (a) Probability to detect bimodality
(i.e., super-infection) in the frequency distribution of the number of mismatches per pair of sequences as a function of the number of bulk-PCR
products analysed and for subjects for which EPD-PCR revealed a super-infection (n=6); (b) Probability to detect bimodality in the frequency
distribution of the number of mismatches per pair of sequences as a function of the number of bulk-PCR products analysed and for subjects for
which EPD-PCR revealed a single infection (n=4). Shown are median, quartiles, minimum and maximum, of the respective probabilities per subject.
doi:10.1371/journal.pone.0036570.g002
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Individual EPD network Clone network
EPD-PCR
haplotypes
Number of
sequences
Haplotype
OP
Bulk-PCR
clone
haplotypes
Haplotype
OP
Number and origin
of sequences
#
B1* 1 13 0,93 a 0,36 16B
2 2 2 b 0,26 36C
2 2 2 c 0,1 26A
211d
* 0,5 26E
3 1 0,07 2 2 2
B2 1 11 0,88 a 0,48 26A, 46B, 26C, 16D, 26E
2 2 2 b 0,35 16E
2 1 0,03 2 2 2
3 1 0,03 2 2 2
4 1 0,03 2 2 2
5 1 0,03 2 2 2
B3 11 2 0 , 9 a 0,33 36B, 16C, 26D, 26E
2 2 2 b 0,23 16C
2 2 2 c 0,23 16D
2 1 0,03 2 2 2
3 1 0,03 2 2 2
4 1 0,03 2 2 2
B4 190 , 6 a 0,35 16B, 16C, 16E
2 6 0,4 b 0,26 26D, 16E
2 2 2 c 0,15 26A
T1* 11 0 0 , 9 a 0,37 16E
241b 0,11 16A, 16D
2 2 2 c 0,07 16E
2 2 2 d 0,07 16C
2 2 2 e 0,04 16B, 16D
2 2 f 0,04 26A
3 1 0,09 2 2 2
T2* 1 10 0,89 a 0,33 16B, 36D, 46E
2 2 2 b 0,26 26B
2 2 2 c 0,23 16A
2 1 0,03 2 2 2
3 1 0,03 2 2 2
4 1 0,03 2 2 2
5212 2 2
T3 1 14 0,93 a 0,29 26C, 26D, 26E
2 2 2 b 0,17 16B
2 2 2 c 0,17 16B
2 2 2 d 0,17 16E
2 1 0,07 2 2 2
T4 170 , 5 a 0,32 26A
2 6 0,44 b 0,19 26D, 16E
2 2 2 c 0,05 16E
3 1 0,03 2 2 2
4 1 0,03 2 2 2
T5 260 , 4 a 0,33 16C, 16E
190 , 6 b 0,22 26B, 26D
2 2 2 c 0,11 16E
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when only 100% accurate identifications were considered (both
founder sequences were properly identified in cases of super-
infection; Table S2) and in 77% of the cases when partial
identifications were considered as well (only one of the founder
sequences was properly identified in cases of super-infection; data
not shown).
Simulated Triple Infections
No triple infection case could be evidenced in our experimental
set of samples. We therefore simulated 84 triple infection cases
which were all recognized as super-infection cases, including six
triplets consisting of two interspersed ‘‘clouds’’ plus one more
distant one, i.e., actually cases of double infection similar to those
identified in our experimental panel. Nine randomly selected
simulated triple infections cases were also examined using TCS:
the three highest OPs properly pointed to EPD-PCR sequences
from the three ‘‘clouds’’ in all cases.
Discussion
EPD-PCR
Our results allow addressing the question of the applicability of
EPD-PCR when samples only contain minute quantities of the
targeted retrovirus/provirus. Here we show that in such cases the
amount of biological material required for proper EPD-PCR
analysis can largely exceed the requirements of ‘‘classical’’
standard bulk-PCR assays (with a ca. 30-fold increase). This is in
sharp contrast with applications of EPD-PCR on samples
exhibiting high retroviremia, where requirements in undiluted
cDNA might often be comparable to those of a single bulk-PCR
assay. The magnitude of the increase poses a serious problem
when one considers that limitation of biological material is an
inherent characteristic of samples obtained from wild and
endangered animal populations [17]. In these conditions, biolog-
ical material use has to be optimised so as to allow investigating the
biology and evolution of the broadest possible spectrum of
pathogens. As an example, one could cite the recent use of the
same collection of faecal samples from wild-living chimpanzees for
the investigation of host [35], SIV [15], SFV [4] and Plasmodium
[36] genetics. The implementation of EPD-PCR for the investi-
gation of super-infection might therefore be unreasonable where
‘‘native’’ endpoint dilution of pathogen DNA/RNA is to be
encountered. In such situations, careful alternatives, which would
still allow for a fair depiction of the underlying retroviral/proviral
populations, should be favoured.
There are two main alternatives to EPD-PCR analysis: bulk-
PCR product cloning and sequencing and NGS. Though the latter
strategy would be less labour-intensive and possibly even cheaper
[10], we considered it as likely to produce highly redundant
information where bulk-PCR amplification starts from only a few
template molecules. We therefore focused on bulk-PCR product
cloning and sequencing, which we considered appropriately scaled
to our objectives.
Bulk-PCR Product Cloning and Sequencing
Here we show that bulk-PCR product cloning is more
parsimonious than EPD-PCR, even when gathering several
bulk-PCR products per sample. Thus, in our conditions,
producing five bulk-PCR products required ca. 4-times less
material than performing an equivalent EPD-PCR analysis.
Interestingly, using a comparable amount of material, EPD-PCR
analyses would have resulted in gathering only 4 sequences, in
which case three out of the six aforementioned cases of super-
infection, namely B1, T1 and T2, would have faced a high
probability of going unnoticed: 56%, 29% and 56%, respectively.
This clearly demonstrates that re-scaling EPD-PCR so as to spare
material would significantly alter the probability to detect super-
infection.
However, bulk-PCR product cloning is itself known to yield a
biased view on within host retrovirus/provirus populations, at least
when a detailed view is needed (e.g., stoechiometries of viral
genomes will likely be significantly skewed) [11]. Here, we aimed
at establishing a coherent analytical framework likely to identify
super-infection cases and the respective underlying main strains
from bulk-PCR product cloning results, even where phylogenetic
signal is low (Table S3). Our strategy was two-fold.
We first wanted to establish a statistical method which allows for
the quick identification of super-infection cases from clone
alignments. We show here that using the shape of the mismatch
distribution from clone alignments is a worthy approach. Using
clones stemming from five independent bulk-PCR products, we
reached a satisfying 90% success rate, i.e. rate of agreement with
EPD-PCR results (T3 was the only case with disagreement),
notably identifying the six super-infected individuals. In addition
to yielding robust estimates of the expected results of an EPD-PCR
experiment, the implementation of such a statistic also has the
advantage to allow for a quick assessment of the number of
samples needed to detect super-infection. Here, it suggests that
using clones derived from fewer PCR products (n$3) would still
have allowed for reaching a high success rate (100%) but at the
cost of a rather large false positive rate (up to 60%). This high false
positive rate is however entirely dependent on the inclusion of a
Table 1. Cont.
Individual EPD network Clone network
EPD-PCR
haplotypes
Number of
sequences
Haplotype
OP
Bulk-PCR
clone
haplotypes
Haplotype
OP
Number and origin
of sequences
#
T6* 1 7 0,88 a 0,74 26A, 26B, 16C, 26D, 26E
2 1 0,13 2 2 2
3712 2 2
All EPD-PCR haplotypes are presented, while only those haplotypes getting OP values above the minimum value are shown for bulk-PCR clone sequences. Assumed
founder sequences are highlighted in bold. # origin of sequences refer to the bulk-PCR products from which they originate (e.g., if haplotype a appeared two times in
PCR product B and once in PCR product C, then 26Ba n d1 6C will appear in this column) * individuals for which statistical parsimony analyses produced two separated
networks; here the sum of all OPs will be greater than one as OPs will be calculated independently for each network.
doi:10.1371/journal.pone.0036570.t001
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sequences stemming from the three other individuals results in a
0% false positive rate (when $3 PCR products are considered).
Interestingly, T3 was identified as single-infected by EPD-PCR
analysis, while the global, five bulk-PCR product-based alignment
rather supported a super-infection (the only faulty assignation in
our sample). As the ‘‘second’’ strain evidenced by bulk-PCR
cloning results only appears in one of the PCR products, T3 might
well be a case where bulk-PCR cloning actually revealed a minor
variant whose presence went undetected by EPD-PCR. Accord-
ingly, we interpret the abovementioned high false positive rate as
likely resulting from a sampling artefact. All in all, this case study
therefore illustrates well how a careful use of our statistical
approach could help in ascertaining the most efficient bulk-PCR
based sampling method, e.g., at the very beginning of larger
projects.
The second step of our strategy consisted of identifying
biological sequences with a particular focus on founder sequences,
here understood as sequences having been at the origin of the
infection or as sequences which ultimately became main compo-
nents of the overall retroviral population. One of the most severe
drawback of a bulk-PCR based method when compared to EPD-
PCR indeed lies in the fact that, contrary to EPD-PCR sequences,
many clone sequences are expected to comprise artifactual
mutations [11]. The ability to identify biological sequences from
Taq-modified ones would further support the use of bulk-PCR
derived clone alignments. Theoretically, in-host evolution of
retroviruses/proviruses is likely to be well captured by network
analyses, which should point at such sequences (assuming they
have been sampled). We show here that, in addition to providing
an excellent visual support for the analysis of retroviral/proviral
evolution, networks can also be used to identify truly biological (as
opposed to Taq-error modified) founder sequences, through the
use of OPs (as implemented in TCS [32]). In our study, the highest
OPs in clone networks always pointed at founder sequences which
were supported by EPD-PCR results, and, where super-infection
was assumed, always identified the two founder sequences, when
they had been sampled. Importantly, we also show that network/
OP-based analysis actually supersedes replication-based identifi-
cation of founder sequences, notably exhibiting good performance
where no replicated sequence is available. This good performance
is in striking contrast with the results that would have provided the
only possible alternative method, i.e., phylogenetic analyses.
Though it is sometimes argued that in phylogenetic trees ancestral
sequences should appear as short branches basal to the longer
branches of their descendants [31], it is indeed very unlikely that
Taq-modified sequences will ever be separated from the biological
sequence from which they are derived by a branch receiving
strong statistical support (individual datasets only comprised weak
phylogenetic information; Table S3). Therefore, networks and
TCS-calculated OPs provide a unique, and so far under-explored,
opportunity to identify founder sequences out of the Taq-induced
noise.
The results that we obtain on simulated triple infections (no
triple infection case could be identified from our experimental
dataset) further support the robustness of our two-step algorithm.
Mismatch distributions derived from simulations are indeed
always a better fit to a bimodal distribution model, suggesting
that our statistical tool actually detects deviation from a unimodal
distribution model. On condition that it is known that super-
infection involves more than two major type of sequences (which
will require visual inspection of the networks), TCS-assessed OPs
are also very efficient in identifying more than two likely founder
sequences.
Nevertheless, it should be kept in mind that the method
discussed here, even though all in all robust, remains bulk-PCR-
based. As such, it is potentially heavily influenced by PCR- and/or
sub-cloning-induced selective biases. The latter could presumably
influence the results in both directions, i.e. lead to false negatives
when sequences of one of the infecting group of strains will be
preferentially amplified and/or false positives when sequences of
one minor infecting group of strains will be preferentially
amplified. Selective biases are however unlikely to result in the
ultimate identification of super-infection where individuals are
truly single infected, i.e. where no minor super-infection occurs.
The main problem would therefore lie in accurately determining
the frequency of biologically significant super-infection events,
such as those resulting in several relatively distant strains becoming
quantitatively important players in the overall retroviral popula-
tion. This could however be corrected by applying the same
approach to several genomic markers at one and the same time,
since independent primer pairs are unlikely to result in congruent
selective biases.
To our knowledge, SFV super-infection of wild primates has
only been reported incidentally a couple of times, also in the case
of chimpanzees [4]. Our results therefore provide a first glimpse
into the frequency of SFV super-infection in a natural primate/
retrovirus system. Even though the size of our host sampling
clearly precludes drawing any definitive conclusions, it seems
plausible that super-infection of wild chimpanzees with their
species-specific SFV is common. Such a high preliminary estimate
is both an expected result, since SFV reach very high prevalence
rates in the species [4], and a puzzling finding as SFV, like other
retroviruses, have evolved mechanisms aimed at restricting super-
infection [37]. It clearly underlines how little we know about
retroviral super-infection in the wild, and consequently, the
necessity for further studies to address this question.
Conclusions
Here we present an overall methodology that could stand for an
acceptable alternative to EPD-PCR analysis for studies which
involve the detection of retroviral super-infections from non-
invasive samples. SFV has the slowest evolutionary rates of all
retroviruses [38], which should result in making the task of
identifying super-infection harder than for other members of this
viral family. The fact that our method is efficient in unveiling SFV
super-infection instances thus offers a good perspective for its
implementation for studies focused on other primate retroviruses
such as STLV-1 and SIV.
Supporting Information
Figure S1 Average number of mismatches between
EPD-PCR sequences as a function of the number of
sequences considered. All possible assemblages of two, three,
and so on up to 15 sequences were considered. For each of those
Figure 3. Median joining network of bulk PCR product clone sequences. As in Figure 1, the networks are ordered by infection status. Within
each network, node size is proportional to the frequency of sequence occurrence (total n=25 for each individual). Branch lengths are directly related
to the number of mutations between sequences, with values noted for differences greater than two base pairs. Clone haplotypes a–f (as shown in
Table 1) are noted within or adjacent to their corresponding node. Networks generated using TCS were highly similar (data not shown).
doi:10.1371/journal.pone.0036570.g003
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mean pairwise distances was finally plotted. Appropriate sampling
of the underlying sequence population can be expected to result in
reaching a plateau phase.
(TIF)
Figure S2 Alignment of EPD-PCR and bulk PCR clone
sequences for individual B1.
(JPG)
Table S1 Individual sample characteristics. Samples have
been ordered according to the age of the chimpanzee at the time
of collection. Individuals whose name starts with a T are P. t. verus
from Taı ¨ National Park, Co ˆte d’Ivoire, with a B P. t. schweinfurthii
from Budongo Forest Reserve, Uganda. * According to EPD-
PCR.
(DOC)
Table S2 Quantities of material used in the generation
of EPD-PCR sequences. The total numbers of necessary
experiments are reported in the left section, and those having
finally be performed in EPD-PCR conditions are reported in the
right section. * marks individuals for which it was necessary to re-
extract from the same original faecal bolus to obtain a sufficient
number of EPD-PCR sequences.
(DOC)
Table S3 Additional statistics computed from individ-
ual bulk-PCR clone sequence datasets. EPD-PCR single
infected individuals are greyed, others are super-infected.
$
Category ‘‘Partly resolved’’ is not shown here but was always
under 2.5% and can be deduced from the other values, ‘‘Partly
resolved’’=100%-(‘‘Unresolved’’+’’Resolved’’).
# Support is given
as approximate likelihood ratio test (aLRT) values and is about the
main bipartition observed in corresponding networks. NA: not
assessed.
(DOC)
Table S4 Identification of EDP-PCR founder sequences
from bulk-PCR clone sequence analyses where replica-
tion-based identification is not applicable. Only the most
conservative view (that showing 100% accuracy in identification) is
presented here. Outgroup probabilities (OPs) were computed with
TCS for all possible combinations of bulk-PCR clone alignments
which would not have allowed using replication as a criterion for
EPD-PCR founder sequence identification. * marks a case where
the founder sequences built separate networks consisting of less
than 3 sequences; these were assumed to be negative.
(DOC)
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